Literature DB >> 18269308

Morbidity and mortality associated with Paget's disease of bone: a population-based study.

Robert A Wermers1, Robert D Tiegs, Elizabeth J Atkinson, Sara J Achenbach, L Joseph Melton.   

Abstract

INTRODUCTION: Limited information is available about the clinical features of Paget's disease of bone among unselected patients in the community. We examined morbidity and mortality associated with this condition in a large inception cohort of Olmsted County, MN, residents with a new diagnosis of Paget's disease from 1950 through 1994.
MATERIALS AND METHODS: Survival was estimated using the Kaplan-Meier method. Cox proportional hazards models were used to assess the impact of various covariates on death.
RESULTS: Paget's disease of bone was diagnosed in 236 Olmsted County residents (mean age at diagnosis, 69.6 yr; 55% men). The majority were symptomatic at diagnosis (58%), and the proportion with symptoms did not change from the prescreening era (1950 to June 1974) to the postscreening era (July 1974-1994). Most patients had polyostotic disease (72%), and the pelvis (67%), vertebra (41%), and femur (31%) were the most common sites of involvement. Skeletal complications attributable to Paget's disease included bowing deformities (7.6%), fracture of pagetic bone (9.7%), and osteosarcoma (0.4%). Osteoarthritis was observed in 73% of patients, and 11% had a hip or knee replacement. Nonskeletal complications related to Paget's disease included cranial nerve (0.4%), peripheral nerve (1.7%), and nerve root (3.8%) compression, basilar invagination (2.1%), hypercalcemia (5.2%), and congestive heart failure (3.0%). Hearing loss, noted in 61%, was significantly higher than previously reported.
CONCLUSIONS: Compared with white Minnesota residents, overall survival was slightly better than expected (p = 0.010). No clinical risk factors were identified that were associated with an increased risk of death.

Entities:  

Mesh:

Year:  2008        PMID: 18269308      PMCID: PMC2515478          DOI: 10.1359/jbmr.080215

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  19 in total

Review 1.  Epidemiology of Paget's disease of bone.

Authors:  C Cooper; E Dennison; K Schafheutle; S Kellingray; P Guyer; D Barker
Journal:  Bone       Date:  1999-05       Impact factor: 4.398

2.  Paget's disease of bone in New Zealand: continued decline in disease severity.

Authors:  H R Cundy; G Gamble; D Wattie; M Rutland; T Cundy
Journal:  Calcif Tissue Int       Date:  2004-10-07       Impact factor: 4.333

Review 3.  What is the relationship between Paget's disease of bone and hyperparathyroidism?

Authors:  Maria Luisa Brandi; Alberto Falchetti
Journal:  J Bone Miner Res       Date:  2006-12       Impact factor: 6.741

4.  Clinical determinants of quality of life in Paget's disease of bone.

Authors:  A L Langston; M K Campbell; W D Fraser; G Maclennan; P Selby; S H Ralston
Journal:  Calcif Tissue Int       Date:  2007-01-04       Impact factor: 4.333

5.  Medical care costs of Paget's disease of bone in a privately insured population.

Authors:  Becky A Briesacher; Denise Orwig; Margaret Seton; Mohamed Omar; Kristijan H Kahler
Journal:  Bone       Date:  2005-12-20       Impact factor: 4.398

6.  The threat to medical-records research.

Authors:  L J Melton
Journal:  N Engl J Med       Date:  1997-11-13       Impact factor: 91.245

Review 7.  Hip arthroplasty in patients with Paget's disease.

Authors:  D G Lewallen
Journal:  Clin Orthop Relat Res       Date:  1999-12       Impact factor: 4.176

8.  Total knee replacement in Paget's disease.

Authors:  H U Cameron
Journal:  Orthop Rev       Date:  1989-02

9.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

10.  Update on the epidemiology of Paget's disease of bone.

Authors:  Cyrus Cooper; Nicholas C Harvey; Elaine M Dennison; Tjeerd P van Staa
Journal:  J Bone Miner Res       Date:  2006-12       Impact factor: 6.741

View more
  19 in total

1.  The Implications of the Sequestosome 1 Mutation P392L in Patients with Paget's Disease in a United States Cohort.

Authors:  Margaret Seton; Marc Hansen; Daniel H Solomon
Journal:  Calcif Tissue Int       Date:  2015-12-28       Impact factor: 4.333

2.  Metabolic bone diseases: treating Paget disease: when matters more than how.

Authors:  Jacques P Brown
Journal:  Nat Rev Rheumatol       Date:  2009-12       Impact factor: 20.543

3.  Chiari I Malformation and Basilar Invagination in Fibrous Dysplasia: Prevalence, Mechanisms, and Clinical Implications.

Authors:  Kristen S Pan; John D Heiss; Sydney M Brown; Michael T Collins; Alison M Boyce
Journal:  J Bone Miner Res       Date:  2018-08-03       Impact factor: 6.741

4.  Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management.

Authors:  Joseph L Shaker
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

Review 5.  [Pathological and metabolic bone diseases: Clinical importance for fracture treatment].

Authors:  R Oheim
Journal:  Unfallchirurg       Date:  2015-12       Impact factor: 1.000

Review 6.  Paget's Disease of Bone: Osteoimmunology and Osteoclast Pathology.

Authors:  Emily M Rabjohns; Katlyn Hurst; Arin Ghosh; Maria C Cuellar; Rishi R Rampersad; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-25       Impact factor: 4.806

Review 7.  Diseases affecting bone quality: beyond osteoporosis.

Authors:  Aasis Unnanuntana; Brian J Rebolledo; M Michael Khair; Edward F DiCarlo; Joseph M Lane
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

8.  Osteoblastic osteosarcoma in monostotic Paget's disease.

Authors:  Teresa Calabrò; Andreas F Mavrogenis; Pietro Ruggieri
Journal:  Musculoskelet Surg       Date:  2011-03-16

9.  Increased frequency of impaired fasting glucose and isolated systolic hypertension in Paget's disease of bone.

Authors:  Marco Barale; Vincenzo Cappiello; Ezio Ghigo; Massimo Procopio
Journal:  Endocrine       Date:  2018-10-03       Impact factor: 3.633

Review 10.  Paget disease: when to treat and when not to treat.

Authors:  Frederick R Singer
Journal:  Nat Rev Rheumatol       Date:  2009-08-04       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.